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239 Heart assessment during exercise can predict pulmonary
hypertension (PH) in CF?
S. Favilli2, S. Bresci1, R. Giuntini1, M. Cavicchi1, C. Braggion1. 1Cystic Fibrosis
Centre, A. Meyer Children Hospital, Florence, Italy; 2Cardiology, A. Meyer
Children Hospital, Florence, Italy
Background: PH is recognized as predictor of severe prognosis in CF lung disease.
Left ventricular(LV) systolic or diastolic dysfunction has also been reported.
Aim: to identify possible echocardiographic ﬁndings of cardiac dysfunction during
both rest and exercise in adults with CF.
Methods: 24 patients (pts)(mean age 31.6, range 13−55 yrs; 14 males) with
moderate-severe airway obstruction (mean FEV1 42, range 21–104% pred.) under-
went to spirometry, conventional doppler echocardiography (DE) and tissue doppler
echocardiography (TDE). TDE was performed at the level of lateral and medial
mitral annulus (LMA, MMA), tricuspid annulus (TA), right ventricular (RV) free
wall (FW). RV function was qualitatively assessed in 4 chamber view. Tricuspidal
annular plane systolic excursion (TAPSE) was also measured. Echocardiography
was performed during a incremental exercise test on an ergocycle in 13 pts with
severe lung disease (FEV1< 35% pred.).
Results: Tricuspid regurgitation (TR) was detected in 4/24 (16%) patients, in 2 of
them TR maximum velocity exceeded 3 m/sec. TAPSE (mean value 22.8, range
14−27), RV and LV systolic and diastolic parameters were within normal limits in
all pts. Mean TDE values were normal at all levels (LMA 11.57 cm/s, MMA 8.64
cm/s, TA 9.22 cm/s, RVFW 8.3 cm/s). Dyskinesia of the ventricular septum (VS)
but not TR was shown in 5/13 (38%) pts during exercise. None of these had PH
ﬁndings using DE and TDE. Wall motion was normal at all the other levels.
Conclusions: Using DE and TDE we found no abnormality of systolic and diastolic
RV and LV function and PH in only 2 pts. Using exercise echocardiography VS
dyskinesia was found in about one third of pts with severe lung disease suggesting
effort PH.
240 The autopsy reports: Cor pulmonale in CF patients with aging
J. Lee1, Y.W. Lee1, W.J. Warwick1. 1Minnesota Cystic Fibrosis Center,
Minneapolis, MN, USA
From deﬁnitions provided by the World Health Organization; cor pulmonale (pul-
monary heart disease), pre-terminal and secondary disease in CF patients involve
“hypertrophy of the right ventricle resulting from lung disease.” It is believed
that cor pulmonale in CF is related to the development of lung destruction with
progressive pulmonary hypertension. Although a large amount of study effort has
been directed toward right atrium and ventricle dysfunction in CF patients, very few
studies have been done for left ventricle dysfunction and coronary artery disease. We
examined the 187 autopsy reports (77 males and 110 females) that were requested
and performed with the permission of patients or their family from 1940s to 2000s
with the age distribution from 5 days to 50 years. In evaluations of heart condition
for the autopsied CF patients, 68% showed evidence of cor pulmonale (right side
heart failure) and 20% showed evidence of problems in both ventricles. We grouped
the autopsied CF patients into 4 groups; age at death under 10 years old, b) 10
to 19, c) 20 to 29 and d) over 30 years old to evaluate cardiac dysfunction with
respect to age. Cor pulmonale was presented in 41% of the patients in group (a);
61% in group (b); 85% in group (c) and 85% in group (d). This result showed that
the risk of cor pulmonale in CF patients increased as they aged. The occurrence
and progression of heart failure in CF is individually and circumstantially different.
There is no correlation between pulmonary function tests (PFT) and the appearance
of heart disease in CF patients by observing PFT tracking.
241 Improvement in aerobic ﬁtness and quality of life does not
depend on severity of pulmonary disease in CF patients
A. Jung1, D. Mueller1, T. Radtke1, J. Wildhaber2, B. Knoepﬂi1. 1Alpine
Chindren’s Hospital Davos, Davos, Switzerland; 2Clinique de Pe´diatrie, Hoˆpital
Cantonal Fribourg, Fribourg, Switzerland
Objective: Exercise training programs to improve aerobic ﬁtness are recognized as
essential components of pulmonary rehabilitation except in respiratory insufﬁcient
individuals. The aim of this study was to determine, whether improvement of
aerobic ﬁtness (VO2peak) and quality of life (QoL) during an inpatient rehabilitation
program depend on disease severity, gender or age in Cystic Fibrosis (CF) patients.
Methods: 79 CF subjects (38 females) with a median (quartiles) age of 22.9 years
(15.8, 29.9) were analyzed for change of VO2peak and QoL before and after a
3-weeks inpatient rehabilitation program including daily physical exercise training.
Severity of pulmonary disease was deﬁned according to FEV1 at study entry
(mild >60%, n = 26; moderate 40−60%, n = 26; severe <40% predicted, n = 27).
Inﬂuence of gender and age (<20 yrs, 20−30 yrs, >30 yrs) was investigated.
Results: Both VO2peak and QoL improved signiﬁcantly during the rehabilitation
program for the total population as well as for all subgroups (p< 0.05). Subjects
with mild, moderate and severe lung disease improved VO2peak and QoL in the
same manner (p = 0.643 and p = 0.283, respectively). No differences in improvement
of VO2peak and QoL could be detected between gender (p = 0.206 and p = 0.060,
respectively) and age groups (p = 0.454 and p = 0.907, respectively).
Conclusion: A 3-weeks multidisciplinary rehabilitation including daily exercise
training improves aerobic ﬁtness and QoL in cystic ﬁbrosis patients independently
of disease severity. Patients with severe pulmonary disease and respiratory insufﬁ-
ciency show no differences in trainability compared to mild and moderate affected
subjects.
242* Respiratory exacerbations in children aged 0−3 years in the
Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL)
Study
C.A. Byrnes1, S. Vidmar2, C. Wainwright3, and the ACFBAL Study Group.
1Starship Children’s Hospital & University of Auckland, Auckland, New Zealand;
2CEBU, Royal Children’s Hospital, Melbourne, VIC, Australia; 3QCMRI, Royal
Children’s Hospital, Brisbane, QLD, Australia
Background: Respiratory exacerbations in CF children causes progressive lung
scarring. However, the ‘usual’ exacerbation rate in early years and the importance
of individual clinical features observed is unknown.
Aim: To describe the frequency and clinical parameters associated with respiratory
exacerbations in children with CF diagnosed on newborn screening and followed
prospectively for 3 years.
Methods: All respiratory exacerbations were recorded. Clinical symptoms and
signs, treatment with oral antibiotics, and admissions to hospital for investigation
and/or intravenous antibiotics were documented.
Results: We enrolled 168 children at mean age 3.6mths (SD 1.6) from 8 Aus-
tralasian sites, with 159 (81 boys, 78 girls) completing 3 years. 1132 exacerbations
were recorded with 114 resulting in hospital admission. There was a median of 6
(range 0−20) respiratory exacerbations/child. The rate of exacerbations/year varied
little (mean 2.56, 2.55, 2.59, SD 2.20, 1.93, 1.66) respectively. There was no
difference in exacerbation rate between boys and girls P = 0.55, or between children
on (2.08 95% CI 1.72, 2.52) or not on (2.62 95%CI 2.46, 2.78) antibiotic prophylaxis
with hazard ratio 0.87 (95%CI 0.69, 1.09 P = 0.23). The most common features
associated with exacerbations requiring oral antibiotic treatment was the presence
of cough (94%), wheeze (28%), and crackles (4%).
Conclusion: Australasian children with CF have a rate of 2.6 respiratory exacer-
bations per year in the ﬁrst 3 years with 90% treated in the community and 10%
requiring hospitalisation.
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